Primary Category:
Radiation Oncology, Treatment Protocols
Disease Category:
Other
Status:
Open
Phase II Randomized Trial of Immunotherapy Versus Immunotherapy and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (IMMORTAL)
NCT#04936230
A032002 is reopened to accrual, effective December 19, 2023, with the implementation of Update 3.
